Article Text


OP0006 Distinct mechanisms of il-1 inhibition revealed by in vitro modelling of il-1 receptor accessory protein interactions with il-1/il-1 receptor complex
  1. BC Varnum,
  2. A Witte,
  3. C Vezina,
  4. X Qian
  1. Pharmacology, Amgen, Thousand Oaks, USA


Background IL-1 stimulates cellular responses by interacting with a heterodimeric receptor complex comprised of IL-1 receptor type I (IL-1RI) and IL-1 receptor accessory protein (IL-1RAcP). IL-1 first binds IL-1RI then IL-1RAcP is recruited to this complex. Inhibitors of IL-1 bioactivity may function through inhibiting any aspect of this complex formation. Understanding the mechanism of inhibition of specific inhibitors can shed light on the nature of the interfaces that define a high affinity site for IL-1RAcP binding.

Objectives To model the interaction of IL-1 Receptor Accessory Protein with IL-1 bound IL-1 Receptor using purified recombinant proteins, and assess the mechanism of antagonism for IL-1 inhibitors.

Methods The extracellular domain of IL-1RAcP was expressed and purified. The interaction of IL-1RAcP with IL-1RI, IL-1 and IL-1RI/IL-1 complex was explored in binding assays. Antibodies to IL-1 and IL-1RI have been used to investigate the roles of individual components of the complex. IL-1 bioassays have been developed to validate the in vitro findings.

Results As expected, IL-1RAcP did not interact with either IL-1 or IL-1RI alone, even at high concentrations (100 nM), however, binding to complex was measured to be high affinity (~ 1 nM). Furthermore, purified IL-1RAcP enhanced binding of IL-1 to receptor. Antibodies to IL-1b have been identified which block binding of IL-1/IL-1RI to IL-1RAcP but fail to influence IL-1 binding to receptor.

Conclusion The observation that anti-IL-1beta antibodies can selectively block binding of IL-1RAcP demonstrates a novel mechanism of IL-1 inhibition and supports the hypothesis that IL-1 makes direct contacts with IL-1RAcP. Since IL-1 does not demonstrate any measurable affinity for IL-1RAcP when not bound to IL-1RI, it is likely that additional elements of the binding site are comprised of IL-1RI residues. Future studies mapping the elements of IL-1RAcP involved in the contact points will further define the binding interface.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.